Loading clinical trials...
Loading clinical trials...
A Pilot Study Comparing Olanzapine and Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients Receiving Highly Emetogenic Chemotherapy
Conditions
Interventions
Olanzapine
Aprepitant
Locations
1
United States
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana, United States
Start Date
February 1, 2014
Primary Completion Date
February 1, 2015
Completion Date
March 1, 2015
Last Updated
March 30, 2017
NCT01596413
NCT01362530
NCT02205164
Lead Sponsor
Indiana University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions